Formulation Development White Papers & Articles

  1. Beyond PMI: Solvents As A Key To Sustainable Process Design 7/17/2026

    Discover how data-driven solvent selection helps uncover sustainability opportunities, boost efficiency, and enable smarter process optimization decisions.

  2. How Data-Driven Development Is Transforming Phosphoramidites 7/17/2026

    High-quality phosphoramidites are key to oligonucleotide therapies. Learn how data-driven optimization boosts purity, streamlines manufacturing, speeds scale-up, and supports commercialization.

  3. Three Keys To E&L Success: Study Design, Partner Selection, And Timing 7/16/2026

    Successful E&L planning starts before testing begins. Aligning study design, partner expertise, and timing helps teams focus on the right risks, avoid surprises, and support stronger development.

  4. Patented Process For Olopatadine HCl API Intermediates 7/15/2026

    See how this patented Wittig-based process for olopatadine HCl achieves Z/E isomer ratios up to 4:1, eliminating dangerous reagents like n-butyl lithium while cutting purification complexity.

  5. Platform Strategy For Improving Manufacturability And Efficacy In Bispecific Antibodies 7/15/2026

    Novel bispecific antibody engineering overcomes assembly and manufacturability challenges, enabling scalable production while preserving therapeutic function, stability, purity, and product quality.

  6. Transforming Research Through Lab Automation 7/6/2026

    Self-driving labs bring automation and AI together to transform research. Learn about how continuous experimentation and real-time learning unlock faster insights and more efficient paths to innovation.

  7. What Will It Take To Make MCED And MRD A Reality? 6/30/2026

    Cancer mortality is declining, but the need for earlier action remains. Gain insight into how MCED and MRD are advancing cancer detection and surveillance, helping clinicians identify disease sooner.

  8. Delivering Critical Therapies With Speed And Safety 6/26/2026

    Faster approvals depend on treating regulation as part of development, not the finish line. See how early quality planning and strong agency communication can move therapies toward patients sooner.

  9. Context-First Data For Trustworthy AI In Biopharma 6/26/2026

    Bridge the gap between AI experimentation and enterprise value. Learn how capturing structured, semantically rich data at the point of origin builds regulator-credible AI pipelines.

  10. Scientific Data Is Not AI‑Ready By Default 6/26/2026

    Convert siloed laboratory data into trusted, AI-ready assets. Learn to enforce data integrity principles at the point of origin to streamline analytics and reduce GxP compliance risks.